| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/08/2004 | US6747014 For therapy of inflammatory bowel disorder |
| 06/08/2004 | US6747005 Determining importin alpha activities in presence and absence of camp-response element binding protein which acetylates importin alpha to determine effect on activities, comparing effect in presence and absence of test compound |
| 06/08/2004 | US6747002 Determination, calibration erythropoietin dosage; analyzing using computer |
| 06/08/2004 | US6746865 Nucleic acids encoding for endostatin protein |
| 06/08/2004 | US6746696 Triterpene compositions and methods for use thereof |
| 06/08/2004 | US6746690 Process for producing composite preparation containing nucleic acid |
| 06/08/2004 | US6746675 Hypoglycemic effects and anti-tumor activity |
| 06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |
| 06/08/2004 | CA2091002C Taxane derivatives, their preparation and use in oncology |
| 06/03/2004 | WO2004046358A1 Novel cancer-associated gene |
| 06/03/2004 | WO2004046356A1 EXON 1β OF PDGF RECEPTOR α GENE AND UTILIZATION THEREOF |
| 06/03/2004 | WO2004046193A1 Method of acquiring human monoclonal antibody inhibting cancer cell proliferation |
| 06/03/2004 | WO2004046191A2 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 06/03/2004 | WO2004046188A2 Anti-activated ras antibodies |
| 06/03/2004 | WO2004046161A1 Novel 2’,5’-oligoadenylic acid analogues |
| 06/03/2004 | WO2004046152A1 Diazinopyrimidines |
| 06/03/2004 | WO2004046151A2 Porphyrin derivatives |
| 06/03/2004 | WO2004046146A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 06/03/2004 | WO2004046138A1 Carboxamides |
| 06/03/2004 | WO2004046130A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | WO2004046122A2 Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors |
| 06/03/2004 | WO2004046118A2 2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders |
| 06/03/2004 | WO2004046117A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/03/2004 | WO2004046101A2 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 06/03/2004 | WO2004046094A1 Histone deacetylase inhibitors |
| 06/03/2004 | WO2004045647A1 Amplification of biotin-mediated targeting |
| 06/03/2004 | WO2004045643A1 Remedy for chondroma or chondrosarcoma |
| 06/03/2004 | WO2004045642A1 Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics |
| 06/03/2004 | WO2004045631A1 The use of psoralea corylifolia for anti-infection caused by helicobacter pylori and for treatment of diseases caused by infection of helicobacter pylori |
| 06/03/2004 | WO2004045619A1 Freeze-dried lecithin nanometer powder injection of ursolic acid and it's preparation method |
| 06/03/2004 | WO2004045617A1 Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer |
| 06/03/2004 | WO2004045611A1 Use of a thiazolidinedione for the reduction of side effects of chemotherapy |
| 06/03/2004 | WO2004045602A1 Drug for inhibiting production of matrix metalloprotease-9 |
| 06/03/2004 | WO2004045600A1 Intermediates for aromatic polyketides as selective anticancer and antiviral agents |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045593A2 Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| 06/03/2004 | WO2004045583A1 Liposome |
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004045532A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 06/03/2004 | WO2004045490A2 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
| 06/03/2004 | WO2004035615A3 Factor involved in metastasis and uses thereof |
| 06/03/2004 | WO2004024727A3 Synthesis of indolizines |
| 06/03/2004 | WO2004018419A3 Benzimidazole quinolinones and uses thereof |
| 06/03/2004 | WO2003106974A3 Diagnosis and treatment of chemoresistant tumors |
| 06/03/2004 | WO2003100432A3 Method for identifying immunoreactive peptides |
| 06/03/2004 | WO2003093476A9 Vector with modified protease-dependent tropism |
| 06/03/2004 | WO2003092595A3 Tyrosine kinase inhibitors |
| 06/03/2004 | WO2003089450A3 Fusion polypeptides and methods for inhibiting microbial adhesion |
| 06/03/2004 | WO2003088995A3 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 06/03/2004 | WO2003057159A9 Psoriasin expression by breast epithelial cells |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | WO2003045369A3 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses |
| 06/03/2004 | WO2003024481A3 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 06/03/2004 | WO2003020739A3 Novel lna compositions and uses thereof |
| 06/03/2004 | WO2003018820A3 Mutant recombinant adeno-associated viruses related applications |
| 06/03/2004 | WO2003016567A3 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 06/03/2004 | WO2003006104A8 Lymphatic endothelial cells materials and methods |
| 06/03/2004 | WO2003000928A3 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 06/03/2004 | WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/03/2004 | WO2002069950A8 Tumor treatement with a combination of a substrate of mrp5 and modulators of mrp5 |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106864 Method of predicting stroke evolution utilising mri |
| 06/03/2004 | US20040106803 e.g., 1-[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole; having a tyrosine kinase inhibitory action |
| 06/03/2004 | US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106730 Polymer complexes of glucuronoglucanes |
| 06/03/2004 | US20040106679 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 06/03/2004 | US20040106667 novel specific indazoles exhibiting anticancer activity via the modulation of the activity of proteins, in particular of kinases |
| 06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 06/03/2004 | US20040106648 dioxodihydropyridine derivatives; 2-acyloxy-5-acylaminofuran and acylvinylene imide intermediates; especially tumour growth inhibitors and anti-cancer agents, antibiotics and/or antiviral agents |
| 06/03/2004 | US20040106640 Aryl ether substituted imidazoquinolines |
| 06/03/2004 | US20040106637 detecting the presence or absence of increased S6 kinase activity in said biological sample. |
| 06/03/2004 | US20040106630 Bicyclic protein kinase inhibitors |
| 06/03/2004 | US20040106624 useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |
| 06/03/2004 | US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same |
| 06/03/2004 | US20040106618 3-heteroarylidene-2-indolinone compounds useful in the prevention and treatment of protein kinase related cellular disorders such as cancer |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106615 For treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant |
| 06/03/2004 | US20040106610 Antagonize pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins |
| 06/03/2004 | US20040106608 Novel imidazole compounds as transforming growth factor (TGF) inhibitors |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106595 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof |
| 06/03/2004 | US20040106569 as a downstream target of the PI 3-kinase pathway, preferably as a downstream drug target |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 06/03/2004 | US20040106561 comprises phytoestrogen isolated from red clover or soya, selected from genistein, daidzein, biochanin A, and/or formononetin; for treatment/prevention of cancer |
| 06/03/2004 | US20040106557 Peptide ligands for prostate specific antigen |
| 06/03/2004 | US20040106540 Method of treating cancer |
| 06/03/2004 | US20040106539 Agents for the treatment of viral infections |
| 06/03/2004 | US20040106174 Designing immunogens |
| 06/03/2004 | US20040106155 Method for kidney disease treatment by drug intervention |